Drug Shortage Report for MONTELUKAST

Last updated on 2023-10-06 History
Report ID 192418
Drug Identification Number 02379821
Brand name MONTELUKAST
Common or Proper name MONTELUKAST
Company Name PRO DOC LIMITEE
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 4MG
Dosage form(s) TABLET (CHEWABLE)
Route of administration ORAL ORAL
Packaging size 30,100
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-05-12
Estimated end date 2023-10-06
Actual end date 2023-10-05
Shortage status Resolved
Updated date 2023-10-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2023-10-06 French Compare
v17 2023-10-06 English Compare
v16 2023-10-03 French Compare
v15 2023-10-03 English Compare
v14 2023-10-03 French Compare
v13 2023-10-03 English Compare
v12 2023-09-29 French Compare
v11 2023-09-29 English Compare
v10 2023-08-25 French Compare
v9 2023-08-25 English Compare
v8 2023-07-26 French Compare
v7 2023-07-26 English Compare
v6 2023-07-18 French Compare
v5 2023-07-18 English Compare
v4 2023-05-13 English Compare
v3 2023-05-12 French Compare
v2 2023-05-12 English Compare
v1 2023-05-12 English Compare

Showing 1 to 18 of 18